180 related articles for article (PubMed ID: 34904114)
21. Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease.
Velayos FS; Sandborn WJ
Inflamm Bowel Dis; 2004 Sep; 10(5):657-60. PubMed ID: 15472531
[TBL] [Abstract][Full Text] [Related]
22. Crohn's disease successfully treated with infliximab in a patient receiving hemodialysis: case report and review of the literature.
Chiba M; Tsuda S; Tsuji T; Nakane K; Komatsu M; Miura Y; Ishida T; Shibahara T; Nishimoto T
Medicine (Baltimore); 2014 Aug; 93(7):e54. PubMed ID: 25101989
[TBL] [Abstract][Full Text] [Related]
23. Infliximab therapy for Crohn's-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report.
Akazawa Y; Takeshima F; Yajima H; Imanishi D; Kanda T; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Hayashi T; Nakashima M; Nakao K
BMC Res Notes; 2014 Jun; 7():382. PubMed ID: 24952714
[TBL] [Abstract][Full Text] [Related]
24. Mucosal healing of Crohn's disease in a patient with concurrent systemic lupus erythematosus using infliximab.
Kagaya Y; Sakamoto H; Yano T; Sunada K; Lefor AK; Niki T; Yamamoto H
Clin J Gastroenterol; 2017 Jun; 10(3):244-249. PubMed ID: 28364315
[TBL] [Abstract][Full Text] [Related]
25. Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.
Lu C; Waugh A; Bailey RJ; Cherry R; Dieleman LA; Gramlich L; Matic K; Millan M; Kroeker KI; Sadowski D; Teshima CW; Todoruk D; Wong C; Wong K; Fedorak RN
World J Gastroenterol; 2012 Sep; 18(36):5058-64. PubMed ID: 23049214
[TBL] [Abstract][Full Text] [Related]
26. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Tsoulis DJ; MacDonald JK
Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
[TBL] [Abstract][Full Text] [Related]
27. Development of Spinal Tuberculosis in an Adolescent With Crohn's Disease After Infliximab Therapy: A Case Report With Literature Review.
Jung JH; Choi S; Kang Y; Cho DC; Lee SM; Park TI; Choe BH; Kim D; Kang B
Front Pediatr; 2021; 9():802298. PubMed ID: 35223712
[TBL] [Abstract][Full Text] [Related]
28. Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease.
Beigel F; Jürgens M; Filik L; Bader L; Lück C; Göke B; Ochsenkühn T; Brand S; Seiderer J
Inflamm Bowel Dis; 2009 Aug; 15(8):1240-4. PubMed ID: 19217020
[TBL] [Abstract][Full Text] [Related]
29. Crohn's disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report.
Xiao L; Sun L; Zhao K; Pan YS
World J Gastrointest Oncol; 2021 Apr; 13(4):305-311. PubMed ID: 33889281
[TBL] [Abstract][Full Text] [Related]
30. [Anti-TNF therapy in treatment of luminal Crohn's disease].
Marko B; Prka L
Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
[TBL] [Abstract][Full Text] [Related]
31. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Townsend CM; Parker CE; MacDonald JK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).
Eshuis EJ; Bemelman WA; van Bodegraven AA; Sprangers MA; Bossuyt PM; van Milligen de Wit AW; Crolla RM; Cahen DL; Oostenbrug LE; Sosef MN; Voorburg AM; Davids PH; van der Woude CJ; Lange J; Mallant RC; Boom MJ; Lieverse RJ; van der Zaag ES; Houben MH; Vecht J; Pierik RE; van Ditzhuijsen TJ; Prins HA; Marsman WA; Stockmann HB; Brink MA; Consten EC; van der Werf SD; Marinelli AW; Jansen JM; Gerhards MF; Bolwerk CJ; Stassen LP; Spanier BW; Bilgen EJ; van Berkel AM; Cense HA; van Heukelem HA; van de Laar A; Slot WB; Eijsbouts QA; van Ooteghem NA; van Wagensveld B; van den Brande JM; van Geloven AA; Bruin KF; Maring JK; Oldenburg B; van Hillegersberg R; de Jong DJ; Bleichrodt R; van der Peet DL; Dekkers PE; Goei TH; Stokkers PC
BMC Surg; 2008 Aug; 8():15. PubMed ID: 18721465
[TBL] [Abstract][Full Text] [Related]
33. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
[TBL] [Abstract][Full Text] [Related]
34. Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn's Disease.
Thurlapati A; Gandu SSK; Kulkarni S
Cureus; 2021 Jun; 13(6):e15835. PubMed ID: 34327073
[TBL] [Abstract][Full Text] [Related]
35. Pre-clinical Crohn's disease: diagnosis, treatment and six year follow-up.
Sorrentino D; Avellini C; Geraci M; Vadalà S
J Crohns Colitis; 2014 Jul; 8(7):702-7. PubMed ID: 24411923
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Infliximab Effects on Gastrointestinal Bleeding in Crohn's Disease Using Double-Balloon Endoscopy.
Chowdhury M; Kudara N; Chiba T; Endo M; Akasaka R; Tomita K; Fujiwara S; Mizutani T; Sugai T; Takikawa Y; Suzuki K
Case Rep Gastroenterol; 2009 Jul; 3(2):193-197. PubMed ID: 21103274
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW; Haasnoot ML; D'Haens GR; Buskens CJ; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Mol B; Stokkers PCF; Bemelman WA; Ponsioen CY;
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):900-907. PubMed ID: 32619413
[TBL] [Abstract][Full Text] [Related]
38. Transcending conventional therapies: the role of biologic and other novel therapies.
Sandborn WJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
[TBL] [Abstract][Full Text] [Related]
39. Chronic Inflammatory Demyelinating Polyneuropathy in Patients With Crohn's Disease on Infliximab Therapy.
Almuntashri F; Binyaseen K; Alkhotani A
Cureus; 2021 Oct; 13(10):e19041. PubMed ID: 34858738
[TBL] [Abstract][Full Text] [Related]
40. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
Yamamoto T; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
